{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:25:00Z","timestamp":1771334700007,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100022299","name":"School of Medicine, Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["School of Medicine, Shahid Beheshti University of Medical Sciences"],"award-info":[{"award-number":["School of Medicine, Shahid Beheshti University of Medical Sciences"]}],"id":[{"id":"10.13039\/501100022299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00586-025-08747-7","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T03:18:40Z","timestamp":1743650320000},"page":"1926-1933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rivaroxaban versus enoxaparin as thromboprophylaxis in degenerative spine surgery: a randomized blinded non-inferiority study"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3711-6763","authenticated-orcid":false,"given":"Hamid Reza Khayat","family":"Kashani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9464-2703","authenticated-orcid":false,"given":"Sohrab","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4490-9553","authenticated-orcid":false,"given":"Pooyan","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poorya","family":"Paryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0599-8439","authenticated-orcid":false,"given":"Zahra","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-4813","authenticated-orcid":false,"given":"Naser","family":"Kachoueian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6858-1115","authenticated-orcid":false,"given":"Maryam","family":"Heli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasibeh","family":"Ghalandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6915-6028","authenticated-orcid":false,"given":"Hadi","family":"Esmaily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"8747_CR1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/BF02596427","volume":"1","author":"DM Becker","year":"1986","unstructured":"Becker DM (1986) Venous thromboembolism: epidemiology, diagnosis, prevention. J Gen Intern Med 1:402\u2013411","journal-title":"J Gen Intern Med"},{"issue":"6","key":"8747_CR2","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/jth.12921","volume":"13","author":"M Franchini","year":"2015","unstructured":"Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci PM (2015) Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: reply. J Thromb Haemost 13(6):1164\u20131165","journal-title":"J Thromb Haemost"},{"issue":"2","key":"8747_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","volume":"131","author":"DJ Graham","year":"2015","unstructured":"Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M et al (2015) Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Circulation 131(2):157\u2013164","journal-title":"Circulation"},{"issue":"17","key":"8747_CR4","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","volume":"376","author":"H Calkins","year":"2017","unstructured":"Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH et al (2017) Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med 376(17):1627\u20131636","journal-title":"N Engl J Med"},{"key":"8747_CR5","unstructured":"Hull RD, Garcia DA, Burnett AE (2018) others. Heparin and LMW heparin: Dosing and adverse effects. UpToDate"},{"issue":"6","key":"8747_CR6","doi-asserted-by":"publisher","first-page":"141S","DOI":"10.1378\/chest.08-0689","volume":"133","author":"J Hirsh","year":"2008","unstructured":"Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI (2008) Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 133(6):141S\u2013159S","journal-title":"Chest"},{"issue":"2","key":"8747_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000215283","volume":"16","author":"S Massonnet-Castel","year":"1986","unstructured":"Massonnet-Castel S, Pelissier E, Bara L, Terrier E, Abry B, Guibourt P et al (1986) Partial reversal of low molecular weight heparin (PK 10169) anti-xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation. Pathophysiol Haemost Thromb 16(2):139\u2013146","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"13","key":"8747_CR8","doi-asserted-by":"publisher","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","volume":"9","author":"A Chen","year":"2020","unstructured":"Chen A, Stecker E, Warden A (2020) Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc 9(13):e017559","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"8747_CR9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1517\/13543784.17.6.925","volume":"17","author":"JP Piccini","year":"2008","unstructured":"Piccini JP, Patel MR, Mahaffey KW, Fox KAA, Califf RM (2008) Rivaroxaban, an oral direct factor xa inhibitor. Expert Opin Investig Drugs 17(6):925\u2013937","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"8747_CR10","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1378\/chest.128.5.3775","volume":"128","author":"W Geerts","year":"2005","unstructured":"Geerts W, Ray JG, Colwell CW, Bergqvist D, Pineo GF, Lassen MR et al (2005) Prevention of venous thromboembolism. Chest 128(5):3775\u20133776","journal-title":"Chest"},{"key":"8747_CR11","unstructured":"Sealed Envelope| Power calculator for binary outcome non-inferiority trial. [cited 2023 Dec 30]. Available from: https:\/\/www.sealedenvelope.com\/power\/binary-noninferior\/"},{"issue":"22","key":"8747_CR12","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.106.642074","volume":"114","author":"BI Eriksson","year":"2006","unstructured":"Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK et al (2006) A once-daily, oral, direct factor xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. Circulation 114(22):2374\u20132381","journal-title":"Circulation"},{"issue":"31","key":"8747_CR13","doi-asserted-by":"publisher","first-page":"e20042","DOI":"10.1097\/MD.0000000000020042","volume":"99","author":"KR Sheth","year":"2020","unstructured":"Sheth KR, Bernthal NM, Ho HS, Bergese SD, Apfel CC, Stoicea N et al (2020) Perioperative bleeding and non-steroidal anti-inflammatory drugs: an evidence-based literature review, and current clinical appraisal. Med (Baltim) 99(31):e20042","journal-title":"Med (Baltim)"},{"issue":"1","key":"8747_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12893-021-01442-6","volume":"22","author":"J Tang","year":"2022","unstructured":"Tang J, Lu Q, Li Y, Wu C, Li X, Gan X et al (2022) Risk factors and management strategies for cerebrospinal fluid leakage following lumbar posterior surgery. BMC Surg 22(1):30","journal-title":"BMC Surg"},{"issue":"9","key":"8747_CR15","first-page":"1115","volume":"101","author":"S Takenaka","year":"2019","unstructured":"Takenaka S, Makino T, Sakai Y, Kashii M, Iwasaki M, Yoshikawa H et al (2019) Prognostic impact of intra-and postoperative management of dural tear on postoperative complications in primary degenerative lumbar diseases. Bone \\&. Jt J 101(9):1115\u20131121","journal-title":"Jt J"},{"key":"8747_CR16","doi-asserted-by":"crossref","unstructured":"Huang H-F, Li S-S, Yang X-T, Xie Q, Tian X-B (2018) Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty: a meta-analysis. Med (Baltim).;97(48)","DOI":"10.1097\/MD.0000000000013465"},{"key":"8747_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jocn.2022.08.023","volume":"105","author":"M Shafiei","year":"2022","unstructured":"Shafiei M, Sabouri M, Aminmansour B, Rezvani M, Mahmoodkhani M, Rahmani P et al (2022) Comparison between rivaroxaban versus enoxaparin for venous thromboembolism prophylaxis following spine surgeries, a randomized clinical trial. J Clin Neurosci 105:51\u201357","journal-title":"J Clin Neurosci"},{"issue":"1","key":"8747_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-015-0223-7","volume":"10","author":"W Du","year":"2015","unstructured":"Du W, Zhao C, Wang J, Liu J, Shen B, Zheng Y (2015) Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery. J Orthop Surg Res 10(1):1\u20138","journal-title":"J Orthop Surg Res"},{"issue":"4","key":"8747_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/cts.12471","volume":"10","author":"RA Boyd","year":"2017","unstructured":"Boyd RA, DiCarlo L, Mandema JW (2017) Direct oral anticoagulants vs. enoxaparin for prevention of venous thromboembolism following orthopedic surgery: a dose\u2013response meta-analysis. Clin Transl Sci 10(4):260\u2013270","journal-title":"Clin Transl Sci"},{"issue":"4","key":"8747_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1060028015626435","volume":"50","author":"AL Ricket","year":"2016","unstructured":"Ricket AL, Stewart DW, Wood RC, Cornett L, Odle B, Cluck D et al (2016) Comparison of postoperative bleeding in total hip and knee arthroplasty patients receiving rivaroxaban or enoxaparin. Ann Pharmacother 50(4):270\u2013275","journal-title":"Ann Pharmacother"},{"issue":"10","key":"8747_CR21","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1111\/j.1538-7836.2012.04877.x","volume":"10","author":"J Beyer-Westendorf","year":"2012","unstructured":"Beyer-Westendorf J, L\u00fctzner J, Donath L, Radke OC, Kuhlisch E, Hartmann A et al (2012) Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry. J Thromb Haemost 10(10):2045\u20132052","journal-title":"J Thromb Haemost"},{"issue":"6","key":"8747_CR22","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3111\/13696998.2011.623203","volume":"14","author":"A Duran","year":"2011","unstructured":"Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M (2011) Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer\u2019s perspective. J Med Econ 14(6):824\u2013834","journal-title":"J Med Econ"},{"issue":"11","key":"8747_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1160\/TH12-12-0919","volume":"110","author":"M Monreal","year":"2013","unstructured":"Monreal M, Folkerts K, Diamantopoulos A, Imberti D, Brosa M (2013) Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain. Thromb Haemost 110(11):987\u2013994","journal-title":"Thromb Haemost"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-025-08747-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00586-025-08747-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-025-08747-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T04:55:11Z","timestamp":1748235311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00586-025-08747-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["8747"],"URL":"https:\/\/doi.org\/10.1007\/s00586-025-08747-7","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors did not declare any competing interests related to the study results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}